Cargando…

Vaccination process of immunocompromised patients in the Netherlands: Current challenges and potential solutions

INTRODUCTION: Immunocompromised patients (ICP) have an increased risk for infectious diseases. Vaccines could help reduce this risk. However, ICP do not always receive or are reimbursed for the specific vaccinations on which they are dependent in the Netherlands. This research aims to gain insights...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Laat, Cindy R., Simons, Joost J.M., Westra, Tjalke A., Hiligsmann, Mickaël
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Regular paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336781/ https://www.ncbi.nlm.nih.gov/pubmed/37448977 http://dx.doi.org/10.1016/j.jvacx.2023.100340

Ejemplares similares

Cost-effectiveness of a male catch-up human papillomavirus vaccination program in the Netherlands
por: Simons, Joost J.M., et al.
Publicado: (2022)

An Updated Analysis of the Impact of HPV Vaccination Based on Long-term Effectiveness in the Netherlands
por: Luttjeboer, Jos, et al.
Publicado: (2023)

Meningococcal Serogroup A, C, W(135) and Y Conjugated Vaccine: A Cost-Effectiveness Analysis in the Netherlands
por: Hepkema, Hiltsje, et al.
Publicado: (2013)

Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic Model
por: de Vries, Robin, et al.
Publicado: (2010)

Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands
por: Mollers, Madelief, et al.
Publicado: (2014)

The current practice for cocaine-associated chest pain in the Netherlands
por: Gresnigt, Femke M.J., et al.
Publicado: (2020)

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands
por: Westra, Tjalke A, et al.
Publicado: (2013)

Two cases of Emergomyces pasteurianus infection in immunocompromised patients in the Netherlands
por: Gast, Karin B., et al.
Publicado: (2019)

A Call to Action: Current Challenges and Considerations for COVID-19 Vaccination in Immunocompromised Populations
por: Bonanni, Paolo, et al.
Publicado: (2023)

The cost of healthy versus current diets in the Netherlands for households with a low, middle and high education
por: Hoenink, Jody C., et al.
Publicado: (2022)

HPV vaccination of immunocompromised hosts
por: Garland, S.M., et al.
Publicado: (2017)

Early intervention for subthreshold panic disorder in the Netherlands: A model-based economic evaluation from a societal perspective
por: Ophuis, Robbin H., et al.
Publicado: (2018)

Is it cost‐effective to provide internet‐based interventions to complement the current provision of smoking cessation services in the Netherlands? An analysis based on the EQUIPTMOD
por: Cheung, Kei‐Long, et al.
Publicado: (2017)

Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands
por: Mitchell, Paul Mark, et al.
Publicado: (2022)

Vaccination of Immunocompromised Cats
por: Hartmann, Katrin, et al.
Publicado: (2022)

Identifying the Challenges of “Small” Pathology Residency Programs and Creating Collaborative Solutions
por: McGoey, Robin, et al.
Publicado: (2016)

Testing conditionality with Bourdieu's capital theory: How economic, social, and embodied cultural capital are associated with diet and physical activity in the Netherlands
por: Mudd, Andrea L., et al.
Publicado: (2023)

The motivations, institutions and organization of university-industry collaborations in the Netherlands
por: Bodas Freitas, Isabel Maria, et al.
Publicado: (2017)

Clustering of homicide with other adverse health outcomes in the Netherlands
por: van Breen, J.A., et al.
Publicado: (2022)

Geographic clustering of testicular cancer incidence in the northern part of The Netherlands
por: Sonneveld, D J A, et al.
Publicado: (1999)

Vaccine preferences driving vaccine-decision making of different target groups: a systematic review of choice-based experiments
por: Diks, Marilyn Emma, et al.
Publicado: (2021)

Produce prescription projects: Challenges, solutions, and emerging best practices – Perspectives from health care providers
por: Stotz, Sarah A., et al.
Publicado: (2022)

Animal products, calcium and protein and prostate cancer risk in the Netherlands Cohort Study
por: Schuurman, A G, et al.
Publicado: (1999)

Urban density differences in colorectal cancer screening participation and screening yield in The Netherlands
por: de Klerk, Clasine M., et al.
Publicado: (2022)

The Current State of Antifungal Stewardship in Immunocompromised Populations
por: Alegria, William, et al.
Publicado: (2021)

Differences in non-positive intention to accept the COVID-19 booster vaccine between three countries in the cross-border region Meuse-Rhine Euroregion: The Netherlands, Belgium, and Germany
por: van Bilsen, Céline J.A., et al.
Publicado: (2023)

The successful COVID-19 vaccine rollout in Chile: Factors and challenges
por: Castillo, Claudio, et al.
Publicado: (2021)

COVID-19 vaccination in immunocompromised patients
por: Sonani, Bhavin, et al.
Publicado: (2021)

Pneumococcal Vaccination in Immunocompromised Hosts: An Update
por: Froneman, Claire, et al.
Publicado: (2021)

Xenotransplantation: Current Challenges and Emerging Solutions
por: Arabi, Tarek Ziad, et al.
Publicado: (2023)

Risks of mucormycosis in the current Covid-19 pandemic: a clinical challenge in both immunocompromised and immunocompetent patients
por: Monika, P., et al.
Publicado: (2022)

First detection of porcine respirovirus 1 in Germany and the Netherlands
por: Schuele, Leonard, et al.
Publicado: (2021)

Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy
por: Demetri, G D
Publicado: (2001)

Contributions of CenteringPregnancy to women’s health behaviours, health literacy, and health care use in the Netherlands
por: Wagijo, Mary-ann, et al.
Publicado: (2023)

Challenges in the Diagnosis of Invasive Fungal Infections in Immunocompromised Hosts
por: Antinori, Spinello, et al.
Publicado: (2018)

Administration of COVID-19 vaccines in immunocompromised patients
por: Negahdaripour, Manica, et al.
Publicado: (2021)

Vaccines and therapeutics for immunocompromised patients with COVID-19
por: Shoham, Shmuel, et al.
Publicado: (2023)

A survey of the current practice of the informed consent process in general surgery in the Netherlands
por: Leclercq, Wouter KG, et al.
Publicado: (2013)

Yellow fever vaccination for immunocompromised travellers: unjustified vaccination hesitancy?
por: de Jong, Wesley, et al.
Publicado: (2019)

Diversity in EWAS: current state, challenges, and solutions
por: Breeze, Charles E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gie5a6sks3qpo1ha9f5vmlgh8d